Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
March 11, 1991
Systolic Hypertension of the Elderly Program (SHEP). Part 10: Analysis
J Wittes, B Davis, K Berge, et al.
Vaccine
|
December 2, 1999
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
J J Treanor, K Kotloff, R F Betts, et al.
Controlled Clinical Trials
|
October 1, 1993
Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP)
B R Davis, J Wittes, S Pressel, et al.
Controlled Clinical Trials
|
April 1, 1992
Quality control of dietary data collection in the CARDIA study
J E Hilner, A McDonald, L Van Horn, et al.
JAMA
|
July 20, 1999
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial
K L Nichol, P M Mendelman, K P Mallon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 5, 1997
Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids
B A Clevidence, J T Judd, E J Schaefer, et al.
Archives of Internal Medicine
|
October 10, 1994
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
W B Applegate, S Pressel, J Wittes, et al.
Lancet (London, England)
|
September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group
F Nosten, C Luxemburger, D E Kyle, et al.
Controlled Clinical Trials
|
October 2, 2001
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop
V G De Gruttola, P Clax, D L DeMets, et al.
The New England Journal of Medicine
|
August 7, 1999
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
H B Rubins, S J Robins, D Collins, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Hypertension (Dallas, Tex. : 1979)
|
March 11, 1991
Systolic Hypertension of the Elderly Program (SHEP). Part 10: Analysis
J Wittes, B Davis, K Berge, et al.
Vaccine
|
December 2, 1999
Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
J J Treanor, K Kotloff, R F Betts, et al.
Controlled Clinical Trials
|
October 1, 1993
Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP)
B R Davis, J Wittes, S Pressel, et al.
Controlled Clinical Trials
|
April 1, 1992
Quality control of dietary data collection in the CARDIA study
J E Hilner, A McDonald, L Van Horn, et al.
JAMA
|
July 20, 1999
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial
K L Nichol, P M Mendelman, K P Mallon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 5, 1997
Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids
B A Clevidence, J T Judd, E J Schaefer, et al.
Archives of Internal Medicine
|
October 10, 1994
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
W B Applegate, S Pressel, J Wittes, et al.
Lancet (London, England)
|
September 14, 1996
Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group
F Nosten, C Luxemburger, D E Kyle, et al.
Controlled Clinical Trials
|
October 2, 2001
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop
V G De Gruttola, P Clax, D L DeMets, et al.
The New England Journal of Medicine
|
August 7, 1999
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
H B Rubins, S J Robins, D Collins, et al.
Page
of 6